Literature DB >> 33926651

Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.

Hao Cui1, Hartzell V Schaff2, Juliano Lentz Carvalho1, Rick A Nishimura3, Jeffrey B Geske3, Joseph A Dearani1, Brian D Lahr4, Alexander T Lee4, J Martijn Bos5, Michael J Ackerman5, Steve R Ommen3, Joseph J Maleszewski6.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by multiple pathological features including myocyte hypertrophy, myocyte disarray, and interstitial fibrosis.
OBJECTIVES: This study sought to correlate myocardial histopathology with clinical characteristics of patients with obstructive HCM and post-operative outcomes following septal myectomy.
METHODS: The authors reviewed the pathological findings of the myocardial specimens from 1,836 patients with obstructive HCM who underwent septal myectomy from 2000 to 2016. Myocyte hypertrophy, myocyte disarray, interstitial fibrosis, and endocardial thickening were graded and analyzed.
RESULTS: The median age at operation was 54.2 years (43.5 to 64.3 years), and 1,067 (58.1%) were men. A weak negative correlation between myocyte disarray and age at surgery was identified (ρ = -0.22; p < 0.001). Myocyte hypertrophy (p < 0.001), myocyte disarray (p < 0.001), and interstitial fibrosis (p < 0.001) were positively associated with implantable cardioverter-defibrillator implantation. Interstitial fibrosis (p < 0.001) and endocardial thickening (p < 0.001) were associated with atrial fibrillation pre-operatively. In the Cox survival model, older age (p < 0.001), lower degree of myocyte hypertrophy (severe vs. mild hazard ratio: 0.41; 95% confidence interval: 0.19 to 0.86; p = 0.040), and lower degree of endocardial thickening (moderate vs. mild hazard ratio: 0.75; 95% confidence interval: 0.58 to 0.97; p = 0.019) were independently associated with worse post-myectomy survival. Among 256 patients who had genotype analysis, patients with pathogenic or likely pathogenic variants (n = 62) had a greater degree of myocyte disarray (42% vs. 15% vs. 20%; p = 0.022). Notably, 13 patients with pathogenic or likely pathogenic genetic variants of HCM had no myocyte disarray.
CONCLUSIONS: Histopathology was associated with clinical manifestations including the age of disease onset and arrhythmias. Myocyte hypertrophy and endocardial thickening were negatively associated with post-myectomy mortality.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  histology; hypertrophic cardiomyopathy; interstitial fibrosis; myocyte disarray; myocyte hypertrophy

Year:  2021        PMID: 33926651     DOI: 10.1016/j.jacc.2021.03.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies.

Authors:  Andreas A Giannopoulos; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2022-08-01       Impact factor: 3.872

2.  Case Report: Treatment of Hypertrophic Cardiomyopathy With Stereotactic Body Radiotherapy.

Authors:  Longzihui Xiao; Jiayi Liu; Yingzhe Zhang; Yuefei Liu; Yan Tang; Minping Zhang; Zhuyuan Ding; Enhua Xiao; Taili Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-01

3.  Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  Daokun Sun; Hartzell V Schaff; Rick A Nishimura; Jeffrey B Geske; Joseph A Dearani; Steve R Ommen
Journal:  JTCVS Tech       Date:  2021-11-01

4.  BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens.

Authors:  Jacob C Scherba; Marc K Halushka; Nicholas D Andersen; Joseph J Maleszewski; Andrew P Landstrom; Nenad Bursac; Carolyn Glass
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.379

5.  Mechanism of Action of Zhi Gan Cao Decoction for Atrial Fibrillation and Myocardial Fibrosis in a Mouse Model of Atrial Fibrillation: A Network Pharmacology-Based Study.

Authors:  Lei Gao; Chenjing Kan; Xin Chen; Shengsong Xu; Kaihu Shi
Journal:  Comput Math Methods Med       Date:  2022-06-09       Impact factor: 2.809

6.  Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.

Authors:  George Bazoukis; Sebastian Garcia-Zamora; Göksel Çinier; Sharen Lee; Enes Elvin Gul; Jesús Álvarez-García; Gabi Miana; Mert İlker Hayıroğlu; Gary Tse; Tong Liu; Adrian Baranchuk
Journal:  World J Cardiol       Date:  2022-09-26

7.  Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.

Authors:  Sotirios Nedios; Borislav Dinov; Timm Seewöster; Frank Lindemann; Sergio Richter; Arash Arya; Nikolaos Dagres; Daniela Husser; Andreas Bollmann; Gerhard Hindricks; Andreas Müssigbrodt
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.